The mRNA vaccines offer hope for the treatment of cancer, Petros Karayiannis, Professor of Microbiology/Molecular Virology at the School of Medicine of the University of Nicosia, told the Cyprus News Agency. But he went on to clarify that the structure of the study and trials carried out by specialists, have not yet been disclosed. The response to the treatment in lung cancer patients is eagerly awaited, he said. According to Professor Karayiannis the same technology was used against the coronavirus with success as it turned out that serious hospitalizations were prevented. But, he noted, these vaccines did not completely prevent the possible infection. There was hope, he said, that the same technology could also be used against other pathogens that cause chronic infections, such as HIV or viral hepatitis. The Professor explained that in the past this technology was used in combination with other inventions in mice against melanoma and the results were very encouraging. The new efforts carried out are f or lung cancer in combination with another drug, he explained. Karayiannis also said that this vaccine will be used in many countries, on a number of patients to determine whether it is effective for everyone. He explained that phase I includes the study of side effects, the reactions on patients that have already been diagnosed. The Professor explained that phases II and III of clinical trials are necessary if this vaccine is to be licensed in the future. Source: Cyprus News Agency